STAT+: Nation’s top cancer hospitals slap hefty markups on drugs, study says

A new study finds health insurers paid drastically different prices for common cancer therapies at top cancer hospitals.

The nation’s preeminent cancer hospitals are charging commercial health insurers anywhere from double to seven times their costs of acquiring cancer drugs, a new study shows.

Most top cancer institutions also are keeping their drug prices secret in direct violation of federal law, potentially exposing themselves to fines.

Continue to STAT+ to read the full story…